Clinical Trials Logo

Myocardial Perfusion Imaging clinical trials

View clinical trials related to Myocardial Perfusion Imaging.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06047028 Recruiting - Clinical trials for Myocardial Perfusion Imaging

'Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

Start date: June 30, 2023
Phase:
Study type: Observational

Heart failure due to coronary artery disease represents a significant cause of mortality. The detection of patients eligible for bypass surgery is a pivotal concern. Nevertheless, the optimal approach for patient selection based on conventional imaging scans remains unclear. The proposed method (Hyperpolarized 13C MRI) has gained extensive use in evaluating in vivo metabolism. This method avoids ionizing radiation and provides critical insights into cardiac function. The feasibility study aims to investigate this method for patient selection before bypass surgery. This innovative imaging technique facilitates the identification of two simple molecules, bicarbonate and lactic acid, produced at high rates by normal heart metabolism. Both bicarbonate and lactate originate from the same precursor molecule, pyruvate. The data generated from this study holds the potential to refine diagnostic precision.

NCT ID: NCT03937921 Recruiting - Clinical trials for Magnetic Resonance Imaging

Dotarem Evaluation for Myocardial Perfusion CMR

Start date: July 3, 2019
Phase:
Study type: Observational

The overall goal of this study is to investigate the signal intensity and relaxation rate characteristics of gadoterate meglumine (Dotarem, Guerbet, USA) enhanced myocardium during rest and stress perfusion cardiovascular magnetic resonance (CMR) compared to gadobutrol (Gadavist) to prove that Dotarem provides constantly high myocardial relaxation necessary for accurate quantitative perfusion evaluation. The purpose of this study is to compare two types of contrast that patients receive during cardiac MRI scans to visualize the blood flow in the cardiac muscle. Both contrasts are used in standard of care procedures, and the one administered for each patient will be randomly selected. The length of the MRI study all procedures are the same as the clinically indicated scan.

NCT ID: NCT03150342 Recruiting - Clinical trials for Hypertrophic Cardiomyopathy

Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging

Start date: May 8, 2017
Phase: N/A
Study type: Observational

Chest pain and myocardial ischemia are prevailing features in patients with hypertrophic cardiomyopathy (HCM). Recently introduced single-photon emission computed tomography (SPECT) cameras with solid-state cadmium-zinc-telluride (CZT) detectors have been shown to decrease imaging time and improved the imaging quality of gated myocardial perfusion imaging (MPI). The investigators also correlate the MPI parameters with echocardiographic parameters. This study is to examine the spatial distribution of stress perfusion abnormalities and tissue injury in patients with HCM using a CZT SPECT camera.